Induction of LaborNCT06324279
Cervical Sliding Sign to Predict Outcome of Induction of Labor
An observational study of Induction of Labor and Transvaginal Ultrasound: Cervical Sliding Sign, run by Ain Shams Maternity Hospital at 1 site in Egypt.
Trial summary
Assess the role of transvaginal ultrasound specifically a sign called cervical sliding sign, in the prediction of success of induction of labor. The prediction of outcome of induction of labor has always been an important topic to all obstetricians. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Induction of Labor, Transvaginal Ultrasound: Cervical Sliding Sign
- What is being tested?
- Transvaginal ultrasound and Misoprostol 200mcg Tab
- Type of treatment
- Medical device
- How many people
- 130 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Sep 2023to 1 Apr 2024
- How long will I take part?
- 2 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: The study will be conducted on term pregnant women with Singleton living fetus attending Ain Shams University Maternity Hospital for induction of labor
Who may be able to join
- 1. women age: from 18 to 45 years old.
- 2. Single living term fetus with gestational age ≥ 37 weeks.
- 3- Eligible for IOL. 4- Bishop score <6 5- Estimated fetal weight < 4Kg.
Who cannot join
- 1- previous caesarean section. (increases risk of rupture uterus) 2- Multiple pregnancy, IUFD, preterm or macrosomic fetus (defined as fetus
- >4.5kg or fetus of diabetic mother >4Kg) (increases risk of shoulder dystocia) 3- Women with major uterine anomalies. (appendix A: ESHRE/ESGE classification for Female genital tract anomalies (Grimbizis GF, et al,. 2013) (increases risk of CS) 4- Vasa previa, placenta previa (increases risk of antepartum hemorrhage) 5- previous myomectomy reaching the endometrial cavity. (Increases risk of rupture uterus) 7- patient refuse to participate or inability to consent. (patient's right to refuse).
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Cervical Sliding Sign as a Marker in Prediction of Successful Induction of Labor
Assess the role of transvaginal ultrasound specifically a sign called cervical sliding sign, in the prediction of success of induction of labor.
The prediction of outcome of induction of labor has always been an important topic to all obstetricians. Bishop score is traditionally considered reliable way to predict the outcome of induction of labor by assessing the cervical dilatation, effacement, position, and consistence and assessing the level of the fetal head in the birth canal. Since The bishop score remains a highly subjective method for prediction of outcome of induction of labor, the use of sonographic measurements such as cervical sliding sign can be a better predictor of successful induction of labor.The presence of CSS was defined as the sliding of the anterior cervical lip on the posterior one under gentle pressure of the transvaginal probe.
Patients undergoing induction of labor with misoprostol will be checked for the cervical sliding sign. The mode of delivery, induction to active labor time and active labor to delivery time will be recorded and analysed to assess whether the sliding sign is an independent predictor of success of induction.
Read the detailed description
Induction of labor is a common practice in modern obstetrics. It is the use of mechanical or pharmacological -or both ways- to stimulate uterine contractions before spontaneous labor to induce cervical dilatation and delivery. Induction of labor at term have many advantages. It can reduce to risk of still birth. It also reduces the risk of macrosomia and its adverse outcomes such as maternal trauma, shoulder dystocia or the need for instrumental delivery (Kim, et al., 2019). However, induction of labor can also have adverse outcomes, the most common is failure and increasing the risk of cesarean section. Induction of labor may not be tolerated by some patients because of the potential increase in the duration of labor or a prolonged latent phase. Increased cost compared to spontaneous delivery course and possible neonatal morbidity if the gestational age is less than 39 weeks of gestation are other drawbacks. (Kim, et al., 2019) Since the success of induction of labor is related to the condition of the cervix, investigators have proposed the importance of having a reliable system for determining the cervical maturity. A number of studies considered the use of sonographic measurement of cervical length to predict the success of labor induction. The sonographic marker for assessing the cervical softening called the cervical sliding sign (CSS) which was introduced by (Volpe, et al., 2019), demonstrated its correlation with the occurrence of impending delivery in women with preterm uterine contractions. The performance of the CSS in predicting the success of IOL was conducted in two academic centers by (Volpe, et al., 2022). However, its generalizability to community hospitals cannot be certain and needs further testing. The presence of CSS was defined as the sliding of the anterior cervical lip on the posterior one under gentle pressure of the transvaginal probe. (Volpe, et al., 2022)
Aim/ Objectives. Assess the role of the cervical sliding sign (CSS) as a marker in the prediction of the outcome of induction of labor (IOL) at term gestation.
Research Hypothesis:
The presence of Cervical Sliding sign in pregnant women at term gestation planned for Induction of labor predicts a higher chance of vaginal delivery within 24 hours.
Research Question:
Is CSS a successful marker for prediction of outcome of induction of labor in pregnant women at term gestation? Methodology
Type of Study: Prospective observational cohort study Study Setting: Ain Shams University Maternity Hospital (labor ward). Study period: 6 months Study Population: The study will be conducted on term pregnant women with Singleton living fetus attending Ain Shams University Maternity Hospital for induction of labor with the following criteria:
Inclusion criteria:
- women age: from 18 to 35 years old.
- Single living term fetus with gestational age ≥ 37 weeks. 3- Eligible for IOL. 4- Bishop score <6 5- Estimated fetal weight < 4Kg.
Exclusion criteria:
- previous caesarean section. (increases risk of rupture uterus)
- Multiple pregnancy, IUFD, preterm or macrosomic fetus (defined as fetus >4.5kg or fetus of diabetic mother >4Kg) (increases risk of shoulder dystocia)
- Women with major uterine anomalies. (appendix A: ESHRE/ESGE classification for Female genital tract anomalies (Grimbizis GF, et al,. 2013) (increases risk of CS)
- Vasa previa, placenta previa (increases risk of antepartum hemorrhage)
- previous myomectomy reaching the endometrial cavity. (Increases risk of rupture uterus)
7- patient refuse to participate or inability to consent. (patient's right to refuse).
Sample Size and sample Size Justification:
Using the PASS 15 program for sample size calculation, reviewing results from a previous study (Volpe et al.2022) showed that the cervical sliding sign (CSS) was found in 48% of the study group (non-consecutive series of uncomplicated singleton term pregnancies, planned for IOL, with a fetus in cephalic presentation patients), based on this frequency and after 20% adjustment for dropout rate, a sample size of at least 130 participants produces a two-sided 95% confidence interval with a width equal to 0.199 when the sample proportion is 0.480.
Ethical Consideration:
This study will be done after approval of the ethical committee of the department of obstetrics and gynecology, faculty of medicine, Ain Shams University. Informed consent will be taken from all participants before recruitment in the study, and after explaining the purpose and procedures of the study. The investigator will obtain the written, signed informed consent of each subject prior to performing any study specific procedures on the subject. The investigator will retain the original signed informed consent form. All laboratory specimens, evaluation forms, reports, video recordings and other records that leave the site will not include unique personal to maintain subject confidentiality. The study will be based on the investigator self-funding.
Study procedures and interventions:
Women fitting into our inclusion criteria will be subjected to:
- history taking (personal, obstetric, medical and surgical)
- Transvaginal ultrasound to assess the presence of CSS with a semi-filled bladder using a 10 MHz endo-vaginal probe EC3-10T of Alpinion E-CUBE 5 ultrasound machine (ALPINION MEDICAL SYSTEMS Co., Ltd. Guro-gu, Seoul, 08393, Republic of Korea) will be done by the most senior resident. "The CSS will be evaluated as follows:
1- acquisition of a sagittal view of the cervix, on which the internal and external os and the endocervical canal could be identified. 2- Gentle pressure with the transvaginal probe on the cervix until maximum compression of the cervix is achieved. 3- Visualization of the anterior cervical lip "sliding" on the posterior one is defined as the presence of CSS." (Volpe, et al., 2022) 3- Induction and management of labor will be conducted following the hospital's protocol (APPENDEX B: FIGO MISOPROSTOL-ONLY RECOMMENDED REGIMENS 2017(Morris JL, et al., 2017)) 4- record the mode of delivery for each participant either vaginal delivery or cesarean deliveries. 5- Measurement of induction-to-active-labor1 time (active labor time defined as ≥ 6cm dilated cervix), active-labor-to-delivery time, total length of labor.
Outcomes:
- 1ry outcome: successful vaginal delivery.
- 2ry outcomes:
- induction-to-active-labor time interval.
- Active -labor-to-delivery time interval.
- Mode of Delivery (vaginal/ Instrumental/ Cesarean)
- Reason for CS (Fetal distress/ failure of induction/ failure of progress).
Statistical analysis:
- All data will be collected, tabulated, and statistically analyzed by software package program
- Being tested
- Transvaginal ultrasound, Misoprostol 200mcg Tab
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transvaginal ultrasoundDevice
Transvaginal ultrasound will be used to see the presence of cervical sliding sign
Misoprostol 200mcg TabDrug
Induction of labor by misoprostol
| Study group | Role | What they receive |
|---|---|---|
| term pregnant women with Singleton living fetus attending for induction of labor | Not described Receives: Device: Transvaginal ultrasound; Drug: Misoprostol 200mcg Tab |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mode of delivery
Vaginal or cesarean section
Measured: 48 hours
Induction to active labor time
Start of induction till cervical dilation of 6 cm
Measured: 48 hours
Active labor to delivery time
From cervical dilation of 6 cm till delivery of fetus
Measured: 10 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Mar 2024
- Study start1 Sep 2023
- Primary completion1 Apr 2024 (estimated)
- Study completion1 Apr 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Induction of LaborStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 130 participants (actual)
- Target duration
- 2 Days
Sponsor and investigators
- Lead sponsor
- Ain Shams Maternity Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Omaima Abbas Mahmoud, Ain Shams Maternity Hospital
- Investigators
- Omaima A Mahmoud, mbchb, Principal investigator, Ainshams university faculty of medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06324279
- Sponsor's protocol ID
- 000017585
- Status last verified
- Mar 2024
- First submitted
- 15 Mar 2024
- Last updated
- 21 Mar 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- Yes
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 21 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Cervical Sliding Sign as a Marker in Prediction of Successful Induction of Labor
- ClinicalTrials.gov ID
- NCT06324279
- Acronym / sponsor ID
- 000017585
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 130 participants (actual)
- Lead sponsor
- Ain Shams Maternity HospitalUniversity, hospital or other
- Study start
- 1 Sep 2023 (actual)
- Primary completion
- 1 Apr 2024 (estimated)
- Study completion
- 1 Apr 2024 (estimated)
- First posted
- 21 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Assess the role of transvaginal ultrasound specifically a sign called cervical sliding sign, in the prediction of success of induction of labor.
The prediction of outcome of induction of labor has always been an important topic to all obstetricians. Bishop score is traditionally considered reliable way to predict the outcome of induction of labor by assessing the cervical dilatation, effacement, position, and consistence and assessing the level of the fetal head in the birth canal. Since The bishop score remains a highly subjective method for prediction of outcome of induction of labor, the use of sonographic measurements such as cervical sliding sign can be a better predictor of successful induction of labor.The presence of CSS was defined as the sliding of the anterior cervical lip on the posterior one under gentle pressure of the transvaginal probe.
Patients undergoing induction of labor with misoprostol will be checked for the cervical sliding sign. The mode of delivery, induction to active labor time and active labor to delivery time will be recorded and analysed to assess whether the sliding sign is an independent predictor of success of induction.
Detailed description
Induction of labor is a common practice in modern obstetrics. It is the use of mechanical or pharmacological -or both ways- to stimulate uterine contractions before spontaneous labor to induce cervical dilatation and delivery. Induction of labor at term have many advantages. It can reduce to risk of still birth. It also reduces the risk of macrosomia and its adverse outcomes such as maternal trauma, shoulder dystocia or the need for instrumental delivery (Kim, et al., 2019). However, induction of labor can also have adverse outcomes, the most common is failure and increasing the risk of cesarean section. Induction of labor may not be tolerated by some patients because of the potential increase in the duration of labor or a prolonged latent phase. Increased cost compared to spontaneous delivery course and possible neonatal morbidity if the gestational age is less than 39 weeks of gestation are other drawbacks. (Kim, et al., 2019) Since the success of induction of labor is related to the condition of the cervix, investigators have proposed the importance of having a reliable system for determining the cervical maturity. A number of studies considered the use of sonographic measurement of cervical length to predict the success of labor induction. The sonographic marker for assessing the cervical softening called the cervical sliding sign (CSS) which was introduced by (Volpe, et al., 2019), demonstrated its correlation with the occurrence of impending delivery in women with preterm uterine contractions. The performance of the CSS in predicting the success of IOL was conducted in two academic centers by (Volpe, et al., 2022). However, its generalizability to community hospitals cannot be certain and needs further testing. The presence of CSS was defined as the sliding of the anterior cervical lip on the posterior one under gentle pressure of the transvaginal probe. (Volpe, et al., 2022)
Aim/ Objectives. Assess the role of the cervical sliding sign (CSS) as a marker in the prediction of the outcome of induction of labor (IOL) at term gestation.
Research Hypothesis:
The presence of Cervical Sliding sign in pregnant women at term gestation planned for Induction of labor predicts a higher chance of vaginal delivery within 24 hours.
Research Question:
Is CSS a successful marker for prediction of outcome of induction of labor in pregnant women at term gestation? Methodology
Type of Study: Prospective observational cohort study Study Setting: Ain Shams University Maternity Hospital (labor ward). Study period: 6 months Study Population: The study will be conducted on term pregnant women with Singleton living fetus attending Ain Shams University Maternity Hospital for induction of labor with the following criteria:
Inclusion criteria:
- women age: from 18 to 35 years old.
- Single living term fetus with gestational age ≥ 37 weeks. 3- Eligible for IOL. 4- Bishop score <6 5- Estimated fetal weight < 4Kg.
Exclusion criteria:
- previous caesarean section. (increases risk of rupture uterus)
- Multiple pregnancy, IUFD, preterm or macrosomic fetus (defined as fetus >4.5kg or fetus of diabetic mother >4Kg) (increases risk of shoulder dystocia)
- Women with major uterine anomalies. (appendix A: ESHRE/ESGE classification for Female genital tract anomalies (Grimbizis GF, et al,. 2013) (increases risk of CS)
- Vasa previa, placenta previa (increases risk of antepartum hemorrhage)
- previous myomectomy reaching the endometrial cavity. (Increases risk of rupture uterus)
7- patient refuse to participate or inability to consent. (patient's right to refuse).
Sample Size and sample Size Justification:
Using the PASS 15 program for sample size calculation, reviewing results from a previous study (Volpe et al.2022) showed that the cervical sliding sign (CSS) was found in 48% of the study group (non-consecutive series of uncomplicated singleton term pregnancies, planned for IOL, with a fetus in cephalic presentation patients), based on this frequency and after 20% adjustment for dropout rate, a sample size of at least 130 participants produces a two-sided 95% confidence interval with a width equal to 0.199 when the sample proportion is 0.480.
Ethical Consideration:
This study will be done after approval of the ethical committee of the department of obstetrics and gynecology, faculty of medicine, Ain Shams University. Informed consent will be taken from all participants before recruitment in the study, and after explaining the purpose and procedures of the study. The investigator will obtain the written, signed informed consent of each subject prior to performing any study specific procedures on the subject. The investigator will retain the original signed informed consent form. All laboratory specimens, evaluation forms, reports, video recordings and other records that leave the site will not include unique personal to maintain subject confidentiality. The study will be based on the investigator self-funding.
Study procedures and interventions:
Women fitting into our inclusion criteria will be subjected to:
- history taking (personal, obstetric, medical and surgical)
- Transvaginal ultrasound to assess the presence of CSS with a semi-filled bladder using a 10 MHz endo-vaginal probe EC3-10T of Alpinion E-CUBE 5 ultrasound machine (ALPINION MEDICAL SYSTEMS Co., Ltd. Guro-gu, Seoul, 08393, Republic of Korea) will be done by the most senior resident. "The CSS will be evaluated as follows:
1- acquisition of a sagittal view of the cervix, on which the internal and external os and the endocervical canal could be identified. 2- Gentle pressure with the transvaginal probe on the cervix until maximum compression of the cervix is achieved. 3- Visualization of the anterior cervical lip "sliding" on the posterior one is defined as the presence of CSS." (Volpe, et al., 2022) 3- Induction and management of labor will be conducted following the hospital's protocol (APPENDEX B: FIGO MISOPROSTOL-ONLY RECOMMENDED REGIMENS 2017(Morris JL, et al., 2017)) 4- record the mode of delivery for each participant either vaginal delivery or cesarean deliveries. 5- Measurement of induction-to-active-labor1 time (active labor time defined as ≥ 6cm dilated cervix), active-labor-to-delivery time, total length of labor.
Outcomes:
- 1ry outcome: successful vaginal delivery.
- 2ry outcomes:
- induction-to-active-labor time interval.
- Active -labor-to-delivery time interval.
- Mode of Delivery (vaginal/ Instrumental/ Cesarean)
- Reason for CS (Fetal distress/ failure of induction/ failure of progress).
Statistical analysis:
- All data will be collected, tabulated, and statistically analyzed by software package program
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Days
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| term pregnant women with Singleton living fetus attending for induction of labor | – | Device: Transvaginal ultrasound, Drug: Misoprostol 200mcg Tab |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- The study will be conducted on term pregnant women with Singleton living fetus attending Ain Shams University Maternity Hospital for induction of labor
Key inclusion criteria (3 listed)
- 1. women age: from 18 to 45 years old.
- 2. Single living term fetus with gestational age ≥ 37 weeks.
- 3- Eligible for IOL. 4- Bishop score <6 5- Estimated fetal weight < 4Kg.
Key exclusion criteria (2 listed)
- 1- previous caesarean section. (increases risk of rupture uterus) 2- Multiple pregnancy, IUFD, preterm or macrosomic fetus (defined as fetus
- >4.5kg or fetus of diabetic mother >4Kg) (increases risk of shoulder dystocia) 3- Women with major uterine anomalies. (appendix A: ESHRE/ESGE classification for Female genital tract anomalies (Grimbizis GF, et al,. 2013) (increases risk of CS) 4- Vasa previa, placenta previa (increases risk of antepartum hemorrhage) 5- previous myomectomy reaching the endometrial cavity. (Increases risk of rupture uterus) 7- patient refuse to participate or inability to consent. (patient's right to refuse).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transvaginal ultrasoundTransvaginal ultrasound will be used to see the presence of cervical sliding sign | Device | term pregnant women with Singleton living fetus attending for induction of labor |
| Misoprostol 200mcg TabInduction of labor by misoprostol | Drug | term pregnant women with Singleton living fetus attending for induction of labor |
Primary outcome
Mode of delivery
Time frame: 48 hours
Vaginal or cesarean section
Induction to active labor time
Time frame: 48 hours
Start of induction till cervical dilation of 6 cm
Active labor to delivery time
Time frame: 10 hours
From cervical dilation of 6 cm till delivery of fetus
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Mar 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Induction of Labor
Active, not recruiting
Implementation of a Disparities in Labor Outcomes Dashboard
Labor Induction, Cesarean Birth
Recruiting
The Ophthalmic Artery Doppler Evaluation Prior to Labor Induction and Adverse Intrapartum Fetal Outcomes
Ophthalmic Artery, Labor and Delivery
Not yet recruiting
Safety and Feasibility of the INGA Sensor System for Fetal and Uterine Monitoring During Cervical Ripening
Induced Labor, Cervical Ripening
Active, not recruiting
Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin
Labor Induction, Cesarean Delivery
Recruiting
Ripening Approaches for Prompt Induction and Delivery - Sequential Versus Concurrent Dilapan-S and Misoprostol to Achieve Vaginal Delivery (RAPID-DS)
Nulliparous Women Who Scheduled for Labor Induction, Pregnancy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Omaima A Mahmoud, mbchb principal investigator
Ainshams university faculty of medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Induction of Labor and Transvaginal Ultrasound: Cervical Sliding Sign, run by Ain Shams Maternity Hospital at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 21 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mode of delivery (time frame: 48 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2024.